What's breaking now, across thousands of outlets.
Now could be a good time to take advantage of short-term volatility.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
A small biotech’s stock collapsed after the company reported a Phase 2 failure in a debilitating skin condition. Zura Bio said Monday morning that both doses of its experimental drug tibulizumab fared…
The Green Bay Packers have won five of six games and could be buyers at the NFL's trade deadline.
Africa’s poorest borrowers, which are eligible for the World Bank’s cheapest financing, paid 9.8% interest on new bonds in 2025.
Key PointsTilray is consolidating its operations in Canada to simplify its business and achieve cost savings.
Rabobank's RaboResearch Global Economics & Markets’ FX Strategy team discusses the Japanese Yen’s (JPY) recent outperformance and potential medium-term improvement.
US equity futures rise following the S&P 500’s worst week since April 2025, despite a sharp drop in Nvidia. The chip giant launches an investigation after CEO Jensen Huang admitted to an affair with…
